MUMBAI, India, July 24 -- Intellectual Property India has published a patent application (202611060039 A) filed by Noida Institute Of Engineering And Technology Pharmacy Institute on May 12, 2026, for A Stability Enhanced Peptide Drug Formulation.
Inventors include Dr. Saumya Das; and Shruti Varshney.
The application for the patent was published on July 17, 2026, under issue no. 29/2026.
Abstract: A stability enhanced peptide drug formulation is disclosed for improving storage, handling, and administration stability of a peptide active ingredient. The formulation comprises a peptide active ingredient, buffer module, hydration stabilizer, interfacial protection component, oxidative control component, tonicity adjustment component, and sterile container closure system, optionally with a lyophilized matrix. The coordinated system reduces hydrolysis, oxidation, adsorption, aggregation, and particulate formation while supporting liquid or reconstitutable dosage forms. The formulation is suitable for sterile pharmaceutical delivery through vials, syringes, cartridges, infusion systems, or related devices.
Disclaimer: Curated by HT Syndication.
